Systemic lupus erythematosus and pregnancy.
D000962:Antimalarials / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001323:Autoantibodies; D001402:B-Lymphocytes; D003165:Complement System Proteins / Q000502:physiology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007105:Immune Complex Diseases; D007109:Immunity; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D008221:Lymphoid Tissue / Q000276:immunology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000188:drug therapy; D011379:Prognosis; D013601:T-Lymphocytes
D000962:Antimalarials; D001323:Autoantibodies; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003165:Complement System Proteins; D001241:Aspirin